365 related articles for article (PubMed ID: 30506990)
1. Microarray profiling analysis identifies the mechanism of miR-200b-3p/mRNA-CD36 affecting diabetic cardiomyopathy via peroxisome proliferator activated receptor-γ signaling pathway.
Xu L; Chen W; Ma M; Chen A; Tang C; Zhang C; Cai L
J Cell Biochem; 2019 Apr; 120(4):5193-5206. PubMed ID: 30506990
[TBL] [Abstract][Full Text] [Related]
2. MicroRNA-27a-3p suppression of peroxisome proliferator-activated receptor-γ contributes to cognitive impairments resulting from sevoflurane treatment.
Lv X; Yan J; Jiang J; Zhou X; Lu Y; Jiang H
J Neurochem; 2017 Nov; 143(3):306-319. PubMed ID: 28881034
[TBL] [Abstract][Full Text] [Related]
3. LncRNA TINCR/microRNA-107/CD36 regulates cell proliferation and apoptosis in colorectal cancer via PPAR signaling pathway based on bioinformatics analysis.
Zhang X; Yao J; Shi H; Gao B; Zhang L
Biol Chem; 2019 Apr; 400(5):663-675. PubMed ID: 30521471
[TBL] [Abstract][Full Text] [Related]
4. Long noncoding RNA PVT1 facilitates high glucose-induced cardiomyocyte death through the miR-23a-3p/CASP10 axis.
Yu FR; Xia YW; Wang SB; Xiao LH
Cell Biol Int; 2021 Jan; 45(1):154-163. PubMed ID: 33049089
[TBL] [Abstract][Full Text] [Related]
5. Disruption of the c-Myc/miR-200b-3p/PRDX2 regulatory loop enhances tumor metastasis and chemotherapeutic resistance in colorectal cancer.
Lv Z; Wei J; You W; Wang R; Shang J; Xiong Y; Yang H; Yang X; Fu Z
J Transl Med; 2017 Dec; 15(1):257. PubMed ID: 29258530
[TBL] [Abstract][Full Text] [Related]
6. Silencing of peroxisome proliferator-activated receptor-alpha alleviates myocardial injury in diabetic cardiomyopathy by downregulating 3-hydroxy-3-methylglutaryl-coenzyme A synthase 2 expression.
Wang L; Bi X; Han J
IUBMB Life; 2020 Sep; 72(9):1997-2009. PubMed ID: 32734614
[TBL] [Abstract][Full Text] [Related]
7. CircMAP3K5 promotes cardiomyocyte apoptosis in diabetic cardiomyopathy by regulating miR-22-3p/DAPK2 Axis.
Shen M; Wu Y; Li L; Zhang L; Liu G; Wang R
J Diabetes; 2024 Jan; 16(1):e13471. PubMed ID: 37735821
[TBL] [Abstract][Full Text] [Related]
8. Glucagon-Like Peptide-1 Receptor Agonist Protects Against Diabetic Cardiomyopathy by Modulating microRNA-29b-3p/SLMAP.
Fang P; Ye Z; Li R; She D; Zong G; Zhang L; Xue Y; Zhang K
Drug Des Devel Ther; 2023; 17():791-806. PubMed ID: 36936522
[TBL] [Abstract][Full Text] [Related]
9. LncRNA KCNQ1OT1 Mediates Pyroptosis in Diabetic Cardiomyopathy.
Yang F; Qin Y; Wang Y; Li A; Lv J; Sun X; Che H; Han T; Meng S; Bai Y; Wang L
Cell Physiol Biochem; 2018; 50(4):1230-1244. PubMed ID: 30355944
[TBL] [Abstract][Full Text] [Related]
10. Effects of PPARγ agonist pioglitazone on cardiac fibrosis in diabetic mice by regulating PTEN/AKT/FAK pathway.
Zhang XD; Sun GX; Guo JJ; Hu CC; Sun RC; Yu HC
Eur Rev Med Pharmacol Sci; 2021 Jan; 25(2):812-819. PubMed ID: 33577036
[TBL] [Abstract][Full Text] [Related]
11. Targeting EZH1 and EZH2 contributes to the suppression of fibrosis-associated genes by miR-214-3p in cardiac myofibroblasts.
Zhu WS; Tang CM; Xiao Z; Zhu JN; Lin QX; Fu YH; Hu ZQ; Zhang Z; Yang M; Zheng XL; Wu SL; Shan ZX
Oncotarget; 2016 Nov; 7(48):78331-78342. PubMed ID: 27823969
[TBL] [Abstract][Full Text] [Related]
12. MicroRNA-668-3p Protects Against Oxygen-Glucose Deprivation in a Rat H9c2 Cardiomyocyte Model of Ischemia-Reperfusion Injury by Targeting the Stromal Cell-Derived Factor-1 (SDF-1)/CXCR4 Signaling Pathway.
Gao Z; Gao Q; Lv X
Med Sci Monit; 2020 Jan; 26():e919601. PubMed ID: 31997826
[TBL] [Abstract][Full Text] [Related]
13. miR-34a attenuates myocardial fibrosis in diabetic cardiomyopathy mice via targeting Pin-1.
Zhang XL; Zhang G; Bai ZH
Cell Biol Int; 2021 Mar; 45(3):642-653. PubMed ID: 33289184
[TBL] [Abstract][Full Text] [Related]
14. Perillaldehyde improves diabetic cardiomyopathy by upregulating miR-133a-3p to regulate GSK-3β.
Yu YN; Ren YY; Shao ZL; Chen BL; Cui BY; Chao CY; Guo LJ; Guo S; Zhang MX; Wang SX; Zhu ML; Yin YL; Li P
Eur J Pharmacol; 2023 Aug; 953():175836. PubMed ID: 37329971
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of miR-223 attenuates the NLRP3 inflammasome activation, fibrosis, and apoptosis in diabetic cardiomyopathy.
Xu D; Zhang X; Chen X; Yang S; Chen H
Life Sci; 2020 Sep; 256():117980. PubMed ID: 32561396
[TBL] [Abstract][Full Text] [Related]
16. Knockdown of miR-372-3p Inhibits the Development of Diabetic Cardiomyopathy by Accelerating Angiogenesis via Activating the PI3K/AKT/mTOR/HIF-1
Han Z; Zhao D; Han M; Zhang R; Hao Y
Oxid Med Cell Longev; 2022; 2022():4342755. PubMed ID: 36160704
[TBL] [Abstract][Full Text] [Related]
17. Overexpression of miR-22 attenuates oxidative stress injury in diabetic cardiomyopathy via Sirt 1.
Tang Q; Len Q; Liu Z; Wang W
Cardiovasc Ther; 2018 Apr; 36(2):. PubMed ID: 29288528
[TBL] [Abstract][Full Text] [Related]
18. MicroRNA-128 inhibition attenuates myocardial ischemia/reperfusion injury-induced cardiomyocyte apoptosis by the targeted activation of peroxisome proliferator-activated receptor gamma.
Zeng XC; Li L; Wen H; Bi Q
Mol Med Rep; 2016 Jul; 14(1):129-36. PubMed ID: 27150726
[TBL] [Abstract][Full Text] [Related]
19. miR-130 aggravates acute myocardial infarction-induced myocardial injury by targeting PPAR-γ.
Chu X; Wang Y; Pang L; Huang J; Sun X; Chen X
J Cell Biochem; 2018 Sep; 119(9):7235-7244. PubMed ID: 29761875
[TBL] [Abstract][Full Text] [Related]
20. A circular transcript of
Li M; Ding W; Tariq MA; Chang W; Zhang X; Xu W; Hou L; Wang Y; Wang J
Theranostics; 2018; 8(21):5855-5869. PubMed ID: 30613267
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
